
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Head lice: Dr. Ted Rosen eschews nit picking and updates you on currently effective therapies.
Head lice: Dr. Ted Rosen eschews nit picking and updates you on currently effective therapies.
For more webinar videos,






